NANO-X IMAGING (NASDAQ:NNOX), an innovative medical imaging technology company, today reported financial results for the fourth quarter ended December 31, 2025.
Nanox reported revenue of $3.7 million for the fourth quarter, driven by its ongoing initial system deployments and diagnostic services.
However, the company recorded a net loss of $33.4 million for the period.
This loss was primarily driven by a $17.5 million non-cash impairment charge associated with the restructuring of its manufacturing facilities in South Korea.
Total restructuring charges related to this transition are expected to reach approximately $18 million.
A major highlight of the quarter was the company’s progress in the United States.
Nanox finalized several key distribution agreements, most notably a contract with Howard University to deploy 300 systems.
Currently, Nanox has approximately 36 systems in active deployment, serving as a vanguard for its broader global rollout of the Nanox.ARC.
Further strengthening its digital ecosystem, Nanox closed the acquisition of Nanox Health IT.
This move is intended to integrate advanced artificial intelligence and cloud-based radiology solutions directly into the Nanox hardware stack, providing a "software-as-a-service" (SaaS) revenue stream alongside its "pay-per-scan" hardware model.
In a move to strengthen its executive suite during this commercial ramp-up, Nanox announced the appointment of Guy Nathanzon as Chief Financial Officer, effective August 1, 2026.
Nathanzon brings extensive experience in scaling technology companies and will oversee the company’s capital allocation and manufacturing efficiency initiatives as the South Korean restructuring concludes.